Physician
Pediatrics
Dr. Mark M. Blatter, MD
Mark M. Blatter is an expert in the field of Pediatrics. He went to medical school at Virginia Commonwealth University School of Medicine. He received awards:"Fellow (FAAP)". Dr. Mark M. Blatter is a published doctor as well. He has 51 publications published. The latest was: Comparison of acellular pertussis-diphtheria-tetanus toxoids and Haemophilus influenzae type b vaccines administered separately vs. combined in younger vs. older toddl...
Publications
- Quadrivalent meningococcal (MenACWY-TT) conjugate vaccine or a fourth dose of H. influenzae-N. meningitidis C/Y conjugate vaccine (HibMenCY-TT) is immunogenic in toddl...
- Immunogenicity and reactogenicity of Infanrix™ when co-administered with meningococcal MenACWY-TT conjugate vaccine in toddlers primed with MenHibrix™ and Pediarix™
- Milk protein-based infant formula containing rice starch and low lactose reduces common regurgitation in healthy term infants: a randomized, blinded, and prospective t...
- One or Two Doses of Quadrivalent Meningococcal Serogroups A, C, W-135 and Y Tetanus Toxoid Conjugate Vaccine is Immunogenic in 9-12 Month Old Children.
- Antibody Persistence for up to 5 Years After A Fourth Dose of Haemophilus influenzae Type B and Neisseria Meningitidis Serogroups C and Y-Tetanus Toxoid Conjugate Vacc...
- Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults.
- Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine coadministered with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis ...
- Lactose-free milk protein-based infant formula: impact on growth and gastrointestinal tolerance in infants.
- Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years.
- Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of ...
- The pediatrician's role in preventing cervical cancer.
- Immunogenicity and safety of an inactivated hepatitis a vaccine administered concomitantly with a pneumococcal conjugate vaccine in healthy children 15 months of age.
- Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-val...
- Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule.
- Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type ...
- Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents.
- Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults.
- A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancy.
- Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial.
- High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies.
- Impact of a birth dose of hepatitis B vaccine on the reactogenicity and immunogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Hae...
- Interchangeability of 2 diphtheria-tetanus-acellular pertussis vaccines in infancy.
- Oral pleconaril treatment of picornavirus-associated viral respiratory illness in adults: efficacy and tolerability in phase II clinical trials.
- Immune status of infants fed soy-based formulas with or without added nucleotides for 1 year: part 1: vaccine responses, and morbidity.
- Immune status of infants fed soy-based formulas with or without added nucleotides for 1 year: part 2: immune cell populations.
- Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infants.
- Safety and immunogenicity of four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants.
- Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine.
- Growth of newborn, term infants fed soy formulas for 1 year.
- An acellular pertussis vaccine in healthy adults: safety and immunogenicity. Pennridge Pediatric Associates.
- Comparison of acellular pertussis-diphtheria-tetanus toxoids and Haemophilus influenzae type b vaccines administered separately vs. combined in younger vs. older toddl...
- Reactogenicity and immunogenicity of a three-component acellular pertussis vaccine administered as the primary series to 2, 4 and 6 month old infants in the United Sta...
- Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 4- through 6-year-old children. Elmwood Pediatric Associates, Pennri...
- Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants.
- Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine.
- Safety and immunogenicity of a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine in young infants.
- Immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccine in infants.
- Comparative study of sultamicillin and amoxicillin-clavulanate: treatment of acute otitis media.
- Acellular pertussis vaccination of 2-month-old infants in the United States.
- Immunogenicity of subcutaneous versus intramuscular Oka/Merck varicella vaccination in healthy children.
- Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial.
- Comparison of an acellular pertussis-component diphtheria-tetanus-pertussis (DTP) vaccine with a whole-cell pertussis-component DTP vaccine in 17- to 24-month-old chi...
- Comparison of acellular and whole-cell pertussis-component DTP vaccines. A multicenter double-blind study in 4- to 6-year-old children.
- A comparative study of amoxicillin-clavulanate and amoxicillin. Treatment of otitis media with effusion.
- Cefixime vs. cefaclor in the treatment of acute otitis media in infants and children.
- Sultamicillin (ampicillin-sulbactam) in the treatment of acute otitis media in children.
- Comparison of bacampicillin and amoxicillin in acute otitis media with effusion.
- Quantitative cultures of middle-ear fluid in acute otitis media.
- Duration of effusion after antibiotic treatment for acute otitis media: comparison of cefaclor and amoxicillin.
- Pediatric counseling and subsequent use of smoke detectors.
Schools
Virginia Commonwealth University Medical College Of Virginia School Of Medicine
University Of Pittsburgh Med Center
Doctors Specialties
- Pediatrics
Accepted Insurances
Awards
- Fellow (FAAP)
Education
-
University of Pittsburgh Medical Center -
Virginia Commonwealth University School of Medicine
Helpful Reviews
Similar Doctors
|
Dr. Lisa M. Hwang, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John A. Brungo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hilary M. Garbon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Max K. Chen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sharon N. Cowden, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jessica S. Wallisch, MD |
|
|
Dr. Jerome E. Gloster, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kendra S. Woods, MD |
|
|
Dr. Ann E. Thompson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stacy L. Rosenberg, MD
This Doctor is OpenDoctor Recommended.
|